Accurate assessment of #LungCancer lesions is critical for diagnosis, personalized treatment planning, and monitoring therapy response. While AI has been applied commonly to segment primary lung tumors in recent years, capturing multiple lesions per patient has remained a challenge—until now. Our latest study introduces a three-step AI pipeline for CT scans: bounding box extraction, multi-instance lesion segmentation, and false positive reduction. ▪️ Dataset: 1,081 multicenter CT scans, 5,322 annotated lesions ▪️ Performance: up to 76% Dice similarity, 85% lesion detection sensitivity on independent and real-world datasets This work demonstrates how AI can provide more comprehensive, precise, and robust insights into lung cancer burden, supporting clinicians in delivering tailored care. https://bit.ly/4nCBL9X #WorldLungDay #AIinRadiology #MedicalImaging #DeepLearning #PrecisionMedicine
🇸🇪 If you’re attending ESUR 2025 in Stockholm, make sure to join our Industry Symposium with Philips. Presented by Prof. Philippe PUECH, CHU de Lille, France, we invite you this Friday, September 26, from 12:00 – 12:30 p.m. in Room C1 + C2 to discover how QP-Prostate is enhancing precision MRI for early #ProstateCancer detection, empowering clinicians to make more accurate and informed diagnostic and treatment decisions. Stop by booth 9 or book a demo to see our solutions in action: https://lnkd.in/dEbvHJHM #ESUR2025 #UrogenitalImaging #MedicalInnovation
“𝘐𝘮𝘢𝘨𝘦𝘴 𝘢𝘳𝘦 𝘥𝘪𝘨𝘪𝘵𝘢𝘭 𝘣𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘴𝘢𝘮𝘱𝘭𝘦𝘴 — 𝘪𝘮𝘮𝘰𝘳𝘵𝘢𝘭 𝘢𝘯𝘥 𝘳𝘪𝘤𝘩 𝘪𝘯 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯. 𝘖𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘪𝘴 𝘵𝘰 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮 𝘵𝘩𝘦𝘮 𝘪𝘯𝘵𝘰 𝘣𝘪𝘰𝘮𝘢𝘳𝘬𝘦𝘳𝘴 𝘵𝘩𝘢𝘵 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴, 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵, 𝘢𝘯𝘥 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘰𝘶𝘵𝘤𝘰𝘮𝘦𝘴.” — Ángel Alberich-Bayarri In an exclusive interview for Transformational Growth Leadership, our CEO and Co-Founder shares with Anantharaman K.V., PMP® (Frost & Sullivan) how a research project on imaging biomarkers became our global mission.
Events like the 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘺 𝘛𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘈𝘡𝘪𝘰𝘯 𝘚𝘶𝘮𝘮𝘪𝘵, hosted today by AstraZeneca in Madrid, are essential for sharing knowledge and fostering collaboration across the oncology community. With a focus on the latest advances in drug development and how to enhance clinical practice through innovative technologies, the event brought together key stakeholders driving the future of #cancercare. This year, our Medical Advisor Almudena Fuster Matanzo represented Quibim in the session “AI in Clinical Practice: Success Stories”, joining Siemens and Sycai Medical to highlight disruptive imaging solutions. It was a great opportunity to showcase how innovative tools can unlock the full potential of imaging data and help shape a future where technology and medicine work seamlessly together to transform cancer care. #OncologyInnovation #AIinHealthcare #MedicalImaging
🇫🇷 We are looking forward to participate in the 73rd JFR (Journées Francophones de Radiologie) in Paris, which will take place from October 3-6. This is a great opportunity to explore how AI is transforming medical imaging, improving precision, and optimizing #patientcare. Don’t miss Prof. Philippe PUECH's pitch, "QP-Prostate® : Optimiser la détection du cancer grâce à l´IA", on Friday, October 3rd at 15:05 in the Forum IA. And visit us at booth FIA-10 to meet our experts—Paul Idelson, Javier Pizcueta Pastor and Claire Palacin—who will be happy to show you our AI solutions and discuss how advanced image analysis can help radiologists in their daily practice. 📆 Don't forget to book a demo: https://lnkd.in/dZJjS_aH #JFR2025 #Radiology#AIinHealthcare #MedicalImaging #InnovationinHealthcare
🏆 Excited to share that Quibim has been recognized as one of the Best Small & Medium Workplaces in Europe 2025! A huge thank you to our incredible team of quibimers—your passion and dedication are what make this truly a #GreatPlaceToWork! Great Place To Work #TeamCulture #gptw #BestInEurope #GreatPlacetoWork #EuropesBestWorkplaces25
In the healthcare sector, certifications go far beyond regulatory checkboxes - they are a guarantee of safety, performance and trust for both patients and professionals. Josep Hortigüela, Senior Vice President of Quality Assurance and Regulatory Affairs, took to the stage at the 𝐈 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐅𝐨𝐫𝐮𝐦 in Madrid to share Quibim's regulatory journey. In his talk, “𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘚𝘰𝘧𝘵𝘸𝘢𝘳𝘦. 𝘊𝘌 𝘊𝘦𝘳𝘵𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯. 𝘒𝘦𝘺 𝘗𝘰𝘪𝘯𝘵𝘴 𝘢𝘯𝘥 𝘓𝘦𝘴𝘴𝘰𝘯𝘴 𝘓𝘦𝘢𝘳𝘯𝘦𝘥”, Josep reflected on Quibim's path —three CE certifications under the MDR and three FDA clearances for AI-based SaMD solutions—to reveal what it truly takes to bring certified medical software to market. He emphasized the critical factors for compliance, including lifecycle standards and clinical evaluation, as well as cybersecurity, quality management, and realistic timelines, all essential for delivering safe and effective AI solutions in healthcare. FARMAFORUM 2025 #MedicalDevices #SaMD hashtag#HealthcareInnovation #RegulatoryAffairs #MedTech #PatientSafety
🎗️ 1 in 8 men will be diagnosed with #ProstateCancer during their lifetime, and although localized cases have a five-year survival rate of nearly 100%, this figure drops to 32% when the disease spreads. In a recent pharmaphorum article, our CEO & Co-Founder Ángel Alberich-Bayarri explores how AI-generated images can transform prostate cancer care, enabling earlier detection, reducing unnecessary biopsies, and offering more personalized treatment. Awareness is important. But innovation is what will change outcomes. https://lnkd.in/ddYj5qqR #ProstateCancerAwareness #AIInHealthcare #MedicalImaging #CancerCare
We’re always excited to see advancements in prostate cancer detection that don’t require invasive biopsies. In honor of #ProstateCancerAwarenessMonth, we’re pleased to share this study on a promising noninvasive urine test that identifies prostate cancer using three biomarkers: TTC3, H4C5, and EPCAM. The test detects #ProstateCancer with 91% accuracy, even in PSA-negative patients, and can distinguish cancer from benign conditions like BPH and prostatitis. By reducing unnecessary biopsies, it represents a major step toward safer, earlier, and more precise diagnoses. It’s encouraging to see science opening new paths to earlier, safer, and more precise diagnoses. You can read the full paper here: https://lnkd.in/dtM6gViW #EarlyDetection #MedicalInnovation #HealthcareResearch
Our team members Marta Martinez Calle, Ph.D. and Cristina Lerma Arce are currently participating in the 2025 Annual Conference of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) in Barcelona, Spain. Come by booth #SP02 to learn more about QP-Insights, and don't forget to attend Marta's presentation tomorrow, September 16, from 10:00 to 11:00 a.m., where she will discuss in detail our abstract accepted for this conference: “𝘐𝘯𝘵𝘦𝘳𝘷𝘦𝘯𝘵𝘪𝘰𝘯𝘢𝘭 𝘙𝘢𝘥𝘪𝘰𝘭𝘰𝘨𝘺 𝘐𝘮𝘢𝘨𝘪𝘯𝘨 𝘗𝘭𝘢𝘵𝘧𝘰𝘳𝘮 𝘵𝘰 𝘧𝘰𝘴𝘵𝘦𝘳 𝘔𝘶𝘭𝘵𝘪-𝘐𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘪𝘰𝘯𝘢𝘭 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘚𝘵𝘶𝘥𝘪𝘦𝘴 𝘢𝘯𝘥 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘛𝘳𝘪𝘢𝘭𝘴”. What a great opportunity to interact with colleagues, share knowledge, and advance research in interventional radiology. #CIRSE2025 #InterventionalRadiology #MedicalImaging #ClinicalResearch #QPInsights
